Published in Anti-Infectives Week, October 31st, 2005
"Fungal bloodstream infections are associated with significant patient mortality and health care costs," physicians in the United States explained. "Nevertheless, the relationship between a delay of the initial empiric antifungal treatment until blood culture results are known and the clinical outcome is not well established."
To elucidate this relationship, a "retrospective cohort analysis with automated patient medical records and the pharmacy database at Barnes-Jewish Hospital was conducted" by M. Morrell and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Anti-Infectives Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.